Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Algonomics
company
About
Algonomics provides structural bioinformatics services to develop rationally designed therapeutics in the field of immunotherapy.
- 10001 - max
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €1.50M
- Industries
- Bioinformatics,Biotechnology,Therapeutics
- Founded date
- Jan 1, 1999
- Number Of Employee
- 10001 - max
- Operating Status
- Active
AlgoNomics is a Belgium based biotech company providing structural bioinformatics services to develop rationally designed therapeutics in the broad field of immunotherapy. AlgoNomics owns a rich, proprietary platform for structure-based protein and peptide design. The technology platform contains innovative tools to unravel protein-protein and protein-peptide interactions. AlgoNomics' premier product is the Epibase® platform for T-cell epitope identification in different population groups, applied in the discovery of vaccines and therapeutic proteins.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€1.50M
Algonomics has raised a total of
€1.50M
in funding over 2 rounds. Their latest funding was raised on
Jun 20, 2007 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 20, 2007 | Series Unknown | €1.50M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Algonomics is funded by 2 investors.
Baekeland Funds
and TrustCapital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Baekeland Funds
|
— | Series Unknown |
TrustCapital
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
